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ABSTRACT
Transplantation has become an available and successful treatment option for numerous
congenital and acquired hepatic disorders. Studies have shown that when the prepregnancy
recipient graft function is stable and adequate, pregnancy is normally well tolerated with
favorable neonatal outcomes. However, there are reports of increased incidences of hyper-
tension and preeclampsia as well as lower birth weights and prematurity. Patients administered
tacrolimus-based therapies seem to have lower incidences of these complications.
Case Reports. The 5 reported patients, aged 23–37 years at the time of conception, were
2–11 years posttransplantation. A preterm delivery for fetal distress was the most clinically
important complication among these patients. One episode of acute genital herpes
infection, 1 liver hematoma in a patient who was anticoagulated owing to a history of deep
vein thrombosis, and 1 case of wound infection postpartum were also observed. Despite
these complications, all 5 pregnancies were successful. The mean gestational age at
delivery was 35.2 weeks. No structural malformations or early complications were observed
in the neonates. All cases showed stable liver parameters.
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iTRANSPLANTATION has become an available andsuccessful treatment option for numerous congenital
and acquired hepatic disorders,1 for both acute and chronic
iver failure. Menstrual abnormalities or amenorrhea asso-
iated with extremely reduced fertility are observed in
omen with liver failure, who are frequently anovulatory.2
However, after successful transplantation, many patients
report a fast return of libido, normal menstrual cycles, and
fertility with the clear possibility of pregnancy in women of
reproductive age and normal sexual activity.3 This recovery
of reproductive function after the liver transplant is evi-
denced by the increasing number of pregnancies reported
worldwide.4–11
Over the last 20 –25 years, issues specific to liver
transplantation and pregnancy have been extensively
studied and it seems to be evident that when the prepreg-
nancy recipient graft function is stable and adequate,
pregnancy is normally well tolerated with favorable neo-
natal outcomes.4 However, there are reports of increased
ncidences of hypertension, preeclampsia, and premature
irths, as well as lower birth weights. Studies have not
hown an increased risk of acute graft rejection episodes
r significant deterioration of liver function associated
ith pregnancy if the graft function was stable at the time
f conception.1– 6 There is also no evidence of a specific
alformation pattern among these children.
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Transplantation Proceedings, 43, 1337–1339 (2011)Studies show that there are some differences in the
omplications profile depending on the immunosuppressive
egimen prescribed. Transplant recipients administered
acrolimus-based therapies seem to have lower incidence of
ypertension, preeclampsia, and infection, but a greater
ncidence of insulin-treated diabetes during pregnancy.4–11
We have described 5 cases of pregnancy among women
who had liver transplantation managed from 1991 to 2010.
CASE REPORTS
The State University of Campinas (Unicamp) in Brazil has a
multidisciplinary and skilled staff trained to assist all high-risk
pregnancies at a specialized outpatient prenatal care unit. For
patients who undergo transplantation, an integrated follow-up
involving obstetric care and a liver transplant team are required to
achieve maternal and fetal well-being.
Since 1991, a total of 500 liver transplants have been performed;
162 were women and 34 were of reproductive age. We are
reporting on 5/34 of pregnancy among these patients. From
January 1991 to October, 2010, there were a total of 32,836
deliveries at the maternity unit, which correspond with a very low
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childbirths.
CASE REPORTS
Patient 1
A 26-year old primipara was transplanted in 1991 due to Budd-
Chiari syndrome 4 years before this pregnancy, using cyclosporine
and prednisone 7.5 mg/d. This patient was also being treated for a
hypertensive disorder with propranolol and submitted to anticoag-
ulation therapy after deep venous thrombosis. Pregnancy was
diagnosed around 13 weeks of amenorrhea. At that time, the
anticoagulation regimen was exchanged for low-molecular-weight
heparin (maintaining an international normalized ratio [INR] of
2.5).
At 26 weeks of pregnancy, the patient was admitted for nausea
and abdominal pain. Her laboratory examinations showed negative
investigation for infectious disease, such as HIV, hepatitis, cyto-
megalovirus (CMV), toxoplasmosis, or rubella, and a hemoglobin
level of 10.1 mg/dL. Normal liver and renal function were con-
firmed. During this hospitalization, endoscopy was performed and
showed esophageal varicoses of thin caliber and mild gastritis.
Obstetrical ultrasound showed no abnormalities, with normal
Doppler of the umbilical artery, but abdominal imaging revealed an
enlarged spleen (219  71 mm) and an ecogenic image in her
hepatic right lobe, with 63  31  19 mm interpreted as an
hematoma. At this point, the patient’s hemoglobin level had
dropped to 8.4 mg/dL; however, she was clinically stable, and had
orientation for bedrest and ambulatory evaluation once a week.
At 30 weeks and 4 days of the pregnancy, the patient was again
hospitalized for a blood transfusion (hemoglobin level, 7.5 mg/dL)
and fetal well-being evaluation with normal Doppler ultrasound and
fetal biophysical profile of 8. At 33 weeks and 6 days of the pregnancy,
the patient was admitted for an emergency Cesarean section for fetal
distress, giving birth to a preterm newborn weighing 1,407 g, an Apgar
score of 1/2/8, and postnatal assessment of gestational age (Capurro’s
method) of 33 weeks, with normal follow-up during hospitalization.
The patient recovered well, with no other complications or need for
transfusion. A barrier method was indicated as the contraceptive
choice.
Patient 2
A 31-year-old primiparous woman was transplanted for autoim-
mune hepatitis 2 years before this pregnancy; immunosuppression
consisted of 4 mg tacrolimus and 5 mg prednisone per day. This
patient had normal renal and liver function before conception and
maintained stable laboratory controls through the whole gesta-
tional period with no complications or need for hospital admission.
At 39 weeks and 3 days the patient was hospitalized for labor
induction, with a favorable cervix condition (3 cm dilated), but then
had to be submitted to an emergency Cesarean section due to fetal
distress yielding a healthy newborn with 3465 g, Apgar score 8/9,
and a postnatal assessment of gestational age (Capurro’s method)
of 40 weeks. Again, a barrier method was indicated as contracep-
tive of choice.
Patient 3
A 23-year-old primipara was transplanted due to autoimmune
hepatitis 6 years before this pregnancy; immunosuppression con-
sisted of taking 4.0 mg of tacrolimus per day and 7.5 mg of
prednisone. This patient had normal renal and liver function beforeconception and maintained stable laboratory controls through the
whole gestational period with no complications or need for hospital
admission.
At 36 weeks and 5 days, the patient was admitted in labor and
submitted to an instrumental vaginal delivery, under epidural
analgesia, yielding a healthy, low-weight (2430 g) newborn with an
Apgar score of 9/9 and postnatal assessment of gestational age
(Capurro’s method) of 39 weeks and 2 days. At that time, a tubal
ligation was performed through a periumbilical incision.
Patient 4
A 37-year-old woman was transplanted due to autoimmune hepa-
titis 9 years before this pregnancy; immunosuppression consisted of
2.0 mg of tacrolimus per day and with normal renal and liver
function before conception. The patient had a background of 1 first
trimester abortion 5 years posttransplant. During the first ultra-
sound examination at 12 weeks of gestation, a diagnosis of cystic
hygroma was made; no other abnormalities were noticed, with
normal cariotype and negative investigation for intrauterine infec-
tions, such as toxoplasmosis, rubella, CMV, and syphilis.
At around 28 weeks of pregnancy, the patient had a cutaneous
erythema with vesicles on her abdomen and lower back with the
diagnosis of Herpes zooster, treated with acyclovir for 10 days. At 39
weeks of pregnancy the patient was admitted for spontaneous
rupture of membranes and a Cesarean section was performed due
to active genital herpes infection. A healthy, 3000-g baby, Apgar
score 9/10 and postnatal assessment of gestational age (Capurro’s
method) of 38 weeks and 3 days, was delivered. A barrier method
was indicated for contraception.
Patient 5
A 23-year-old primipara was transplanted due to autoimmune
hepatitis 11 years before this pregnancy; immunosuppression con-
sisted of 5 mg of tacrolimus per day. This patient had normal renal
and liver function before conception and maintained stable labo-
ratory controls throughout the gestational period.
At around 32 weeks of pregnancy, this patient was admitted for
preterm labor. Corticosteroids had already been administered for
fetal lung maturation and inhibition was not tried (the patient was
initially 5 cm dilated). However, a Cesarean section was performed
due to functional dystocia. A healthy, 1990-g baby, Apgar score
8/10 and postnatal assessment of gestational age (Capurro’s
method) of 32 weeks and 3 days, was delivered, with good evolution
after hospital discharge (Table 1).
Immediately postpartum, the patient required a blood transfu-
sion, but recovered very well and was discharged 72 hours later.
Seven days after delivery, the patient was again admitted, this time
for an infected hematoma and urinary tract infection. Intravenous
antibiotics were prescribed and a surgical procedure necessary.
After 4 days she was again discharged with no additional compli-
cations. An intrauterine device (IUD) was indicated as contracep-
tive advice.
In all patients, breastfeeding was contraindicated because of the
immunosuppressive regimen and the patient maintained normal renal
and liver function during the postpartum period.
DISCUSSION
Over the last 2 decades, obstetricians have faced different
kinds of challenges due to medical evolution and the
development of possible treatments for various critical
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PREGNANCY AFTER LIVER TRANSPLANTATION 1339clinical and surgical conditions. Considering the history of
hepatic insufficiency and transplantation, about 20 years
ago it would have been impossible to predict the association
between transplanted patients, immunosuppressive ther-
apy, durability of grafts, and a normal gestation. However,
the number of successful cases of transplantation has
increased enormously with improvements in surgical tech-
niques and safer immunosuppressive regimens, which have
brought a new life perspective to these patients.4–11
According to the literature review, the main cause of loss
of hepatic function in young women is autoimmune hepa-
titis,5–7 which was the disease involved in 3 of these 4 cases.
Reproductive-age women are able to reestablish ovulation
fter transplantation and contraception has become an impor-
ant part of medical counseling. Not only that, but the discus-
ion of which of these patients could plan a gestation and what
ould be necessary during prenatal care is also possible.
Transplanted patients with lower risk during pregnancy
re those who become pregnant 2 years posttransplanta-
ion, have stable and normal hepatic function, have normal
enal function, and whose immunosuppressive therapy is in
aintenance dosage.6 It is also important to know the blood
ype and investigate the serologic status for hepatitis B and
, HIV, toxoplasmosis, rubella, and CMV for each patient.
The ideal condition would be to perform laboratory
nvestigations and promote a psychological evaluation to
ndicate the possibility of pregnancy, with the knowledge
hat a specialized prenatal care is necessary with a multi-
isciplinary team for follow-up, involving not only the
outine examination, but a rigorous fetal well-being control,
ltrasonography for morphologic and growth assessments,
epatic and renal function, potassium dosages, and monthly
MV antigenemia testing.
The immunosuppressive therapy used in the cases re-
orted herein were cyclosporin and tacrolimus, with or
ithout prednisone, which are considered safe during preg-
ancy; both are class C medications in the latest drug and
regnancy recommendation document.7 However, there is
Table 1. Results of Pregnancy
Patient
Maternal
Age (y) Liver Disease
Years After
Transplant
Im
1 26 Budd–Chiari syndrome 4 Cyclos
2 31 Autoimmune hepatitis 2 Tacroli
3 23 Autoimmune hepatitis 5 Tacroli
4 37 Autoimmune hepatitis 8 Tacroli
5 23 Autoimmune hepatitis 11 Tacroli
Abbreviation: C-section, cesarean section.a reported increased risk of intrauterine growth restriction,ypertensive disorders, and prematurity.8 Among the cases
currently reported, only 1 case of preterm birth was re-
corded. Breastfeeding should be discussed in on individual
basis, considering the immunosuppressive regimen used.6–9
Increasing experience with management of transplanted
patients, pregnancy complications, labor, and neonates have
allowed coordinated care and close surveillance for pregnant
women who have undergone transplantation, with a high
number of successful cases worldwide.10,11 The possibility of
ollow-up with frequent blood chemistry tests, serial ultra-
ounds, and infection screening can assess risk factors, associ-
ted disease, and, therefore, predict complications as well as
llow a quick introduction of treatment, when necessary.
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